Marion Curtis

1.8k total citations · 1 hit paper
27 papers, 1.3k citations indexed

About

Marion Curtis is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Marion Curtis has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Immunology and 9 papers in Oncology. Recurrent topics in Marion Curtis's work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Marion Curtis is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Marion Curtis collaborates with scholars based in United States, Germany and Australia. Marion Curtis's co-authors include Ernst Lengyel, W. F. Dunning, Ricardo R. Lastra, Matthias Mann, Fabian Coscia, S. Diane Yamada, Anthony Montag, Mark A. Eckert, Stephanie M. McGregor and Yilin Zhang and has published in prestigious journals such as Nature, Cell and Nature Communications.

In The Last Decade

Marion Curtis

25 papers receiving 1.2k citations

Hit Papers

Proteomics reveals NNMT as a master metabolic regulator o... 2019 2026 2021 2023 2019 100 200 300

Peers

Marion Curtis
Doris R. Siwak United States
Ashish Juvekar United States
Shelley M. Herbrich United States
Flonné Wildes United States
Jingli Hao Australia
Fernando Doñate United States
Weiguo Wu United States
Max Hasmann Germany
Doris R. Siwak United States
Marion Curtis
Citations per year, relative to Marion Curtis Marion Curtis (= 1×) peers Doris R. Siwak

Countries citing papers authored by Marion Curtis

Since Specialization
Citations

This map shows the geographic impact of Marion Curtis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Curtis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Curtis more than expected).

Fields of papers citing papers by Marion Curtis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Curtis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Curtis. The network helps show where Marion Curtis may publish in the future.

Co-authorship network of co-authors of Marion Curtis

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Curtis. A scholar is included among the top collaborators of Marion Curtis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Curtis. Marion Curtis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bassoy, Esen Yonca, Remya Raja, Fabian Coscia, et al.. (2025). Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer. OncoImmunology. 14(1). 2460276–2460276. 1 indexed citations
2.
Raja, Remya, Kiran K. Mangalaparthi, Anil K. Madugundu, et al.. (2025). Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer. Science Advances. 11(8). eads7405–eads7405. 3 indexed citations
3.
Martínez, Diego, Nicole Appel, Haiwei Gu, et al.. (2024). Inverse‐Vaccines for Rheumatoid Arthritis Re‐establish Metabolic and Immunological Homeostasis in Joint Tissues. Advanced Healthcare Materials. 14(5). e2303995–e2303995. 2 indexed citations
4.
Wilson, Eric, Diego Chowell, Remya Raja, et al.. (2024). The electrostatic landscape of MHC-peptide binding revealed using inception networks. Cell Systems. 15(4). 362–373.e7. 1 indexed citations
5.
Inamdar, Sahil, Christopher Wu, Nicole Appel, et al.. (2023). Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice. Nature Communications. 14(1). 5333–5333. 30 indexed citations
6.
Inamdar, Sahil, et al.. (2023). Succinate in the tumor microenvironment affects tumor growth and modulates tumor associated macrophages. Biomaterials. 301. 122292–122292. 14 indexed citations
7.
Inamdar, Sahil, Xiaojian Shi, Jordan R. Yaron, et al.. (2023). Succinate based polymers drive immunometabolism in dendritic cells to generate cancer immunotherapy. Journal of Controlled Release. 358. 541–554. 14 indexed citations
8.
Raja, Remya, Christopher Wu, Esen Yonca Bassoy, et al.. (2022). PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. Journal for ImmunoTherapy of Cancer. 10(12). e005026–e005026. 17 indexed citations
9.
Raja, Remya, et al.. (2021). Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression. Cancers. 13(13). 3327–3327. 4 indexed citations
10.
Hart, Peter C., Tatsuyuki Chiyoda, Xiaojing Liu, et al.. (2019). SPHK1 Is a Novel Target of Metformin in Ovarian Cancer. Molecular Cancer Research. 17(4). 870–881. 60 indexed citations
11.
Eckert, Mark A., Fabian Coscia, Agnieszka Chryplewicz, et al.. (2019). Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature. 569(7758). 723–728. 325 indexed citations breakdown →
12.
Eckert, Mark A., Fabian Coscia, Agnieszka Chryplewicz, et al.. (2019). Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis. The FASEB Journal. 33(S1). 1 indexed citations
13.
Curtis, Marion, Hilary A. Kenny, Abir Mukherjee, et al.. (2018). Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metabolism. 29(1). 141–155.e9. 203 indexed citations
14.
Coscia, Fabian, Ernst Lengyel, Jaikumar Duraiswamy, et al.. (2018). Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer. Cell. 175(1). 159–170.e16. 111 indexed citations
15.
16.
Coscia, Fabian, Karen M. Watters, Marion Curtis, et al.. (2016). Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status. Nature Communications. 7(1). 12645–12645. 154 indexed citations
17.
Kenny, Hilary A., Erin A. White, Min Shen, et al.. (2015). Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. Nature Communications. 6(1). 10649–10649. 131 indexed citations
18.
Dunning, W. F., et al.. (1968). Comparative Carcinogenic Activity of Dimethyl and Trimethyl Derivatives of Benz(a)anthracene in Fischer Line 344 Rats. Experimental Biology and Medicine. 128(3). 720–722. 2 indexed citations
19.
Dunning, W. F. & Marion Curtis. (1958). Effect of a High Protein and High Nucleic Acid Diet on Occurrence of 2- Acetylaminofluorene-induced Cancer in Rats.. Experimental Biology and Medicine. 99(1). 88–91. 3 indexed citations
20.
Dunning, W. F. & Marion Curtis. (1958). The Role of Indole in Incidence of 2-Acetylaminofluorene-Induced Bladder Cancer in Rats.. Experimental Biology and Medicine. 99(1). 91–95. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026